Aideen Ryan, BSc, PhD

@aideenryan.bsky.social

Tumour Immunology enthusiast. Group leader at University of Galway. Interested in fibroblasts, stromal cells and anti-tumour immunity. All views are my own.

Thrilled to have secured Breakthrough Therapy Designation. This will accelerate our ability to bring #CARTcells to more children with #DIPG and brain & spinal cord tumors.

BrainChild Bio@brainchildbio.bsky.social · 2y ago

Breakthrough Therapy designation gives us the possibility to accelerate the development path for BCB-276 as a CAR T-cell therapy to potentially transform treatment of #DIPG, an incurable brain tumor. Our #CARTcells approach opens a new paradigm for other CNS brain tumors. www.brainchildbio.com/press

Failure is always in the background of any creative project; when the experiments are not working or the results don’t seem to make sense. But for discovery, you can’t deny yourself the permission to fail, and we should better teach failure in all its glory.

Bild